Accelerating Psoriatic Arthritis Detection in Patients With Psoriasis: Direct-to-patient Administration of Screening Questionnaires (D2P Screening)

Who is this study for? Patients with psoriasis
What treatments are being studied? Direct-to-patient Administration of Screening Questionnaires
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The overarching goal of this study is to develop a direct-to-patient screening approach that will improve early Psoriatic Arthritis (PsA) detection in patients with psoriasis. Previously developed screening questionnaires were intended for use in the setting of a doctor's office to assist providers with referral decisions. However, these screening questionnaires are infrequently used in routine practice because of limitations with time and resources. The study will aim to develop a practical screening strategy that does not require involvement from dermatologists (or other non-rheumatology providers) and can systematically reach a broad range of psoriasis patients, including patients not attending dermatology clinics. The researchers hypothesize that disseminating questionnaires directly to patients outside of a clinic setting (direct-to-patient approach) will educate patients about their PsA risk and improve early PsA diagnoses.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Have an International Classification of Diseases (ICD) code diagnosis of psoriasis but without a confirmed diagnosis of Psoriatic Arthritis prior to study initiation

• Be age 18 or older

• Be geographically located within a reasonable proximity to the Rheumatology study site

Locations
United States
Pennsylvania
University of Pennsylvania
RECRUITING
Philadelphia
Utah
University of Utah
RECRUITING
Salt Lake City
Contact Information
Primary
Jessica Walsh, M.D.
jessica.walsh@hsc.utah.edu
801-581-4333
Time Frame
Start Date: 2019-07-22
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 18000
Treatments
Experimental: Intervention with Direct Access to Rheumatologist
Psoriasis patients with no prior diagnosis of PsA randomized to receive intervention PsA questionnaire, including instructions on how to directly schedule a rheumatologic evaluation
Experimental: Intervention with Standard of Care Referral
Psoriasis patients with no prior diagnosis of PsA randomized to receive intervention PsA questionnaire, including instructions to talk with their doctor about a referral to a rheumatologist
No_intervention: Control
Psoriasis patients with no prior diagnosis of PsA randomized to not receive an intervention PsA questionnaire
Related Therapeutic Areas
Sponsors
Leads: Jessica Walsh

This content was sourced from clinicaltrials.gov